Carregant...
Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
Soft tissue sarcomas (STS) are heterogeneous rare malignancies comprising ~1% of all solid cancers in adults and including more than 70 histological and molecular subtypes with different pathological and clinical development characteristics. Over the last two decades, the increased knowledge of the...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7174622/ https://ncbi.nlm.nih.gov/pubmed/32351891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00509 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|